(주)셀레브레인
글로벌 유전자·세포치료제 개발을 선도하는 바이오 혁신기업
연혁
-
- 2023
- 12
- Ph.1 IND application for GBM
- 9
- Head office relocated
-
- 2022
- 9
- Relocation of R&D center
- 2
- License-in from Ajou University
-
- 2021
- 12
- Series-A fund raised
- 6
- Renewal of the venture company certification (2021.04 ~ 2024.04)
- 3
- Initiation of Phase 0 trial for rGBM
- 2
- IND approval with Hanmi Pharm. Co., Ltd
-
- 2020
- 4
- Opening of branch office in Gyeonggi-do
-
- 2019
- 12
- License-in from Ajou University
- 9
- Pre A fund raised
- 4
- Certification of a venture company
-
- 2018
- 6
- Seed investment
- 3
- Established as a research institute company of Ajou University
